Gene therapy and oligonucleotide online symposium

Watch these on-demand webinars and discover ways to accelerate your gene therapy and oligonucleotide development. Get the right answers the first time, through precise analytics you can trust.

Easily analyze vectors and nucleic acid biotherapeutics.
  • Proven answers for protein, vaccine and gene therapy analyses
Quickly and confidently analyze your AAV capsid proteins.
  • AAV capsid purity: the control strategy and the evaluation of CE-SDS with LIF detection
  • Purity analysis of adeno-associated virus (AAV) capsid viral proteins using CE-SDS technology
  • Determination of full, partial and empty capsid ratios for adeno-associated virus (AAV) analysis using capillary electrophoresis-based technology
Assess the purity and topology of your AAV plasmids with highly sensitive, robust and reproducible workflows.
  • A sensitive and robust plasmid analysis method by capillary electrophoresis with laser-induced fluorescence detection
  • Minicircle DNA: a new material for CAR-T and AAV vector particles - its development and analysis
Achieve faster candidate selection and shorten development time with your oligonucleotides.
  • Oligonucleotide quantification and characterization by high-resolution LC-MS
  • Highly sensitive oligonucleotide quantification and characterization
  • Confirming gene editing by CRISPR-Cas9 at the protein level using SWATH® Acquisition

Access the online symposium:

By submitting your information, you agree that SCIEX may collect and further process your personal data in accordance with its Privacy Policy.
You may object to receiving further information at any time.

For research use only. Not for use in diagnostic procedures.